P2‐009: DEVELOPMENT OF THE MUSCARINIC CHOLINERGIC PAM VU319 FOR COGNITIVE ENHANCEMENT: PHASE 1 TESTS OF SAFETY AND TARGET ENGAGEMENT
0301 basic medicine
03 medical and health sciences
DOI:
10.1016/j.jalz.2019.06.1231
Publication Date:
2019-10-18T10:57:04Z
AUTHORS (7)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (4)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....